Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified — Trials · CancerIndex

Clinical trials

Registered studies

136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04828174	Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies	suspended	Phase 1	9	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Nov 29, 2023	clinicaltrials
NCT03704714	Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma	suspended	Phase 1 / Phase 2	30	Northwestern UniversityOTHER	1	Aug 15, 2022